NY-ESO-1 (87-111) is an extended peptide fragment from the NY-ESO-1 cancer-testis antigen encompassing multiple overlapping epitopes. Its sequence supports peptide–MHC binding studies and conformational epitope mapping. Researchers employ it to analyze T-cell recognition across broader NY-ESO-1 segments. The peptide aids refined structural immunology of this highly immunogenic protein.
CAT No: M07039
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Emu oil in combination with other active ingredients for treating skin imperfections
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More